AMERISAFE (NASDAQ:AMSF) Posts Earnings Results, Misses Expectations By $0.09 EPS

AMERISAFE (NASDAQ:AMSF) posted its earnings results on Tuesday. The insurance provider reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.53 by ($0.09), FiscalAI reports. AMERISAFE had a net margin of 14.27% and a return on equity of 15.34%.

AMERISAFE Price Performance

AMSF traded down $0.31 during trading hours on Tuesday, reaching $33.98. The company’s stock had a trading volume of 141,450 shares, compared to its average volume of 209,679. AMERISAFE has a fifty-two week low of $29.42 and a fifty-two week high of $47.86. The stock has a market cap of $635.56 million, a PE ratio of 13.98 and a beta of 0.23. The business’s 50-day moving average is $32.24 and its 200-day moving average is $34.03.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of AMSF. Cetera Investment Advisers purchased a new stake in AMERISAFE during the 4th quarter worth $307,000. Federated Hermes Inc. purchased a new stake in shares of AMERISAFE in the fourth quarter worth about $184,000. PharVision Advisers LLC purchased a new stake in shares of AMERISAFE in the third quarter worth about $223,000. BNP Paribas Financial Markets grew its stake in shares of AMERISAFE by 71.3% in the third quarter. BNP Paribas Financial Markets now owns 4,647 shares of the insurance provider’s stock valued at $204,000 after buying an additional 1,934 shares in the last quarter. Finally, Inceptionr LLC grew its stake in shares of AMERISAFE by 18.6% in the third quarter. Inceptionr LLC now owns 5,649 shares of the insurance provider’s stock valued at $248,000 after buying an additional 885 shares in the last quarter. Hedge funds and other institutional investors own 97.41% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on AMSF. Citizens Jmp reduced their price objective on shares of AMERISAFE from $50.00 to $45.00 and set a “market outperform” rating for the company in a research report on Monday, April 13th. Wall Street Zen upgraded shares of AMERISAFE from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 23rd. Truist Financial cut their target price on shares of AMERISAFE from $36.00 to $34.00 and set a “hold” rating for the company in a research note on Thursday, April 23rd. Finally, Weiss Ratings upgraded shares of AMERISAFE from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, July 14th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $44.67.

AMERISAFE Company Profile

Amerisafe, Inc (NASDAQ: AMSF) is a specialty provider of workers’ compensation insurance products and services in the United States. The company focuses on underwriting and managing workers’ compensation policies for small to mid-sized public and private businesses, particularly in higher-hazard industries such as retail, manufacturing, distribution and wholesale. Through its network of independent agents, Amerisafe delivers tailored coverage solutions that combine robust risk management support with loss prevention programs designed to enhance workplace safety.

In addition to core insurance offerings, Amerisafe provides extensive risk control resources, including safety training, on-site consultations and claims management services.